Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Lluch

Showing results (101-110 of 186) with videos related to

Pageof 19
Sort By:
Nature Communications|April 6, 2016
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growthFelipe Slebe, Federico Rojo, Maria Vinaixa, et al.
Frontiers in Oncology|October 5, 2020
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast CarcinomaBirlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, et al.
Cancer Communications (London, England)|April 10, 2025
Deciphering the transcriptomic landscape of early HR<sup>+</sup>/HER2<sup>-</sup> breast cancer in very young womenIris Garrido-Cano, Marta Tapia, Juan Carbonell, et al.
Cancers|April 13, 2023
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast CancerPaula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancerJavier Cortés, Pierre Fumoleau, Giulia Valeria Bianchi, et al.
British Journal of Cancer|July 13, 2016
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinomaFederico Rojo, Abel González-Pérez, Jessica Furriol, et al.
Cancers|July 2, 2021
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast CancerAnna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2011
Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibilityMaider Ibarrola-Villava, Maria Peña-Chilet, Lara P Fernandez, et al.
BMC Cancer|July 23, 2014
MicroRNA profile in very young women with breast cancerMaria Peña-Chilet, Maria T Martínez, Jose A Pérez-Fidalgo, et al.
Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.
Pageof 19

Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
Nature Communications|April 6, 2016
FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growthFelipe Slebe, Federico Rojo, Maria Vinaixa, et al.
Frontiers in Oncology|October 5, 2020
MicroRNA-33b Suppresses Epithelial-Mesenchymal Transition Repressing the MYC-EZH2 Pathway in HER2+ Breast CarcinomaBirlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, et al.
Cancer Communications (London, England)|April 10, 2025
Deciphering the transcriptomic landscape of early HR<sup>+</sup>/HER2<sup>-</sup> breast cancer in very young womenIris Garrido-Cano, Marta Tapia, Juan Carbonell, et al.
Cancers|April 13, 2023
miR-146a-5p Promotes Angiogenesis and Confers Trastuzumab Resistance in HER2+ Breast CancerPaula Cabello, Sandra Torres-Ruiz, Anna Adam-Artigues, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancerJavier Cortés, Pierre Fumoleau, Giulia Valeria Bianchi, et al.
British Journal of Cancer|July 13, 2016
Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinomaFederico Rojo, Abel González-Pérez, Jessica Furriol, et al.
Cancers|July 2, 2021
Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast CancerAnna Adam-Artigues, Iris Garrido-Cano, Juan Antonio Carbonell-Asins, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2011
Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibilityMaider Ibarrola-Villava, Maria Peña-Chilet, Lara P Fernandez, et al.
BMC Cancer|July 23, 2014
MicroRNA profile in very young women with breast cancerMaria Peña-Chilet, Maria T Martínez, Jose A Pérez-Fidalgo, et al.
Breast Cancer Research : BCR|June 24, 2010
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J Creighton, Xiaoyong Fu, Bryan T Hennessy, et al.
Pageof 19